Christine Klaskin
VP of Finance
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Agenus Inc (AGEN) | Vice President, Finance | $298,224 | $332,019 |
| 2025 | MiNK Therapeutics, Inc. (INKT) | Consultant and Former Treasurer | $29,822 | $29,822 |
| 2024 | Agenus Inc (AGEN) | Vice President, Finance | $298,224 | $483,477 |
| 2024 | MiNK Therapeutics, Inc. (INKT) | Treasurer | $29,822 | $29,822 |
| 2023 | Agenus Inc (AGEN) | Vice President, Finance | $296,239 | $712,747 |
| 2023 | MiNK Therapeutics, Inc. (INKT) | Treasurer | $29,624 | $29,624 |
| 2022 | Agenus Inc (AGEN) | Vice President, Finance | $287,178 | $628,125 |
| 2022 | MiNK Therapeutics, Inc. (INKT) | Treasurer | $27,244 | $27,244 |
| 2021 | Agenus Inc (AGEN) | Vice President, Finance | $275,725 | $574,832 |
| 2021 | MiNK Therapeutics, Inc. (INKT) | Treasurer | $20,019 | $20,019 |
| 2020 | Agenus Inc (AGEN) | Vice President, Finance | $285,166 | $507,705 |
Earnings-call appearances
-
MiNK Therapeutics, Inc. Q3 FY2025 Earnings Call2025-12-08
MiNK Therapeutics, Inc. (INKT)
-
MiNK Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-14
MiNK Therapeutics, Inc. (INKT)
-
MiNK Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-15
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q1 FY2025 Earnings Call2025-05-12
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q4 FY2024 Earnings Call2025-03-18
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q4 FY2024 Earnings Call2025-03-11
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-14
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q3 FY2024 Earnings Call2024-11-12
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-13
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q2 FY2024 Earnings Call2024-08-08
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-14
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q1 FY2024 Earnings Call2024-05-07
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-21
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q4 FY2023 Earnings Call2024-03-14
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-09
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q3 FY2023 Earnings Call2023-11-07
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-11
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q1 FY2023 Earnings Call2023-05-09
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-21
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q4 FY2022 Earnings Call2023-03-14
Agenus Inc (AGEN)
-
Agenus Inc Q3 FY2022 Earnings Call2022-11-08
Agenus Inc (AGEN)
-
MiNK Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-03
MiNK Therapeutics, Inc. (INKT)
-
MiNK Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-09
MiNK Therapeutics, Inc. (INKT)
-
Agenus Inc Q2 FY2022 Earnings Call2022-08-09
Agenus Inc (AGEN)
-
Agenus Inc Q1 FY2022 Earnings Call2022-06-29
Agenus Inc (AGEN)
-
Agenus Inc Q4 FY2021 Earnings Call2022-03-01
Agenus Inc (AGEN)
-
Agenus Inc Q3 FY2021 Earnings Call2021-11-09
Agenus Inc (AGEN)
-
Agenus Inc Q2 FY2021 Earnings Call2021-08-09
Agenus Inc (AGEN)
-
Agenus Inc Q1 FY2021 Earnings Call2021-05-06
Agenus Inc (AGEN)
-
Agenus Inc Q4 FY2020 Earnings Call2021-03-15
Agenus Inc (AGEN)
-
Agenus Inc Q3 FY2020 Earnings Call2020-11-16
Agenus Inc (AGEN)
-
Agenus Inc Q1 FY2020 Earnings Call2020-05-07
Agenus Inc (AGEN)